Pharmacological Conditioning is Salvageable by Dexmedetomidine: How a Sedative Can Mitigate I/R Injuries?
作者信息
Maciel Leonardo
机构信息
Instituto de Biofísica Carlos Chagas Filho Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ - Brasil.
Campus Professor Geraldo Cidade Universidade Federal do Rio de Janeiro, Duque de Caxias, RJ - Brasil.
出版信息
Arq Bras Cardiol. 2023 Nov;120(10):e20230696. doi: 10.36660/abc.20230696.
Abstract
摘要
相似文献
1
Pharmacological Conditioning is Salvageable by Dexmedetomidine: How a Sedative Can Mitigate I/R Injuries?
Arq Bras Cardiol. 2023 Nov;120(10):e20230696. doi: 10.36660/abc.20230696.
2
Dexmedetomidine--a novel sedative for postoperative sedation.
Intensive Crit Care Nurs. 2000 Oct;16(5):328-9. doi: 10.1054/iccn.2000.1529.
3
Dexmedetomidine in cancer surgeries: Present status and consequences with its use.
Indian J Cancer. 2020 Jul-Sep;57(3):234-238. doi: 10.4103/ijc.IJC_376_19.
4
Dexmedetomidine: pediatric pharmacology, clinical uses and safety.
Expert Opin Drug Saf. 2011 Jan;10(1):55-66. doi: 10.1517/14740338.2010.512609. Epub 2010 Aug 18.
5
Dexmedetomidine: more than a sedative and analgesic.
Acta Anaesthesiol Taiwan. 2008 Dec;46(4):149-50. doi: 10.1016/S1875-4597(09)60001-1.
6
Dexmedetomidine and pulmonary artery pressure in the pediatric cardiac surgery patient--A new insight.
Pediatr Crit Care Med. 2010 Sep;11(5):634-5. doi: 10.1097/PCC.0b013e3181d505e3.
7
Perioperative uses of dexmedetomidine.
Int Anesthesiol Clin. 2013 Spring;51(2):81-96. doi: 10.1097/AIA.0b013e31828d58c7.
8
Dexmedetomidine.
Curr Opin Crit Care. 2001 Aug;7(4):221-6. doi: 10.1097/00075198-200108000-00002.
9
Is dexmedetomidine an ideal sedative agent for neurosurgical patients?
Anaesth Intensive Care. 2012 Nov;40(6):927-8. doi: 10.1177/0310057X1204000603.
10
Dexmedetomidine--does it have a role in the perioperative setting?
J Perianesth Nurs. 2005 Aug;20(4):289-91. doi: 10.1016/j.jopan.2005.06.003.
本文引用的文献
1
Dexmedetomidine Preconditioning Attenuates Myocardial Ischemia/Reperfusion Injury in Rats by Suppressing Mitophagy Via Activating Α2-Adrenergic Receptor.
Arq Bras Cardiol. 2023 Oct;120(10):e20220750. doi: 10.36660/abc.20220750.
2
Mitophagy for cardioprotection.
Basic Res Cardiol. 2023 Oct 5;118(1):42. doi: 10.1007/s00395-023-01009-x.
3
Dexmedetomidine attenuates myocardial ischemia/reperfusion-induced ferroptosis via AMPK/GSK-3β/Nrf2 axis.
Biomed Pharmacother. 2022 Oct;154:113572. doi: 10.1016/j.biopha.2022.113572. Epub 2022 Aug 18.
4
Dexmedetomidine Attenuates Ferroptosis-Mediated Renal Ischemia/Reperfusion Injury and Inflammation by Inhibiting ACSL4 α2-AR.
Front Pharmacol. 2022 Jun 14;13:782466. doi: 10.3389/fphar.2022.782466. eCollection 2022.
5
Dexmedetomidine post-conditioning alleviates myocardial ischemia-reperfusion injury in rats by ferroptosis inhibition via SLC7A11/GPX4 axis activation.
Hum Cell. 2022 May;35(3):836-848. doi: 10.1007/s13577-022-00682-9. Epub 2022 Feb 25.
6
Mammalian AKT, the Emerging Roles on Mitochondrial Function in Diseases.
Aging Dis. 2022 Feb 1;13(1):157-174. doi: 10.14336/AD.2021.0729. eCollection 2022 Feb.
7
Dexmedetomidine Resists Intestinal Ischemia-Reperfusion Injury by Inhibiting TLR4/MyD88/NF-κB Signaling.
J Surg Res. 2021 Apr;260:350-358. doi: 10.1016/j.jss.2020.11.041. Epub 2020 Dec 28.
8
Myocardial ischaemia-reperfusion injury and cardioprotection in perspective.
Nat Rev Cardiol. 2020 Dec;17(12):773-789. doi: 10.1038/s41569-020-0403-y. Epub 2020 Jul 3.
9
The PINK1-Parkin axis: An Overview.
Neurosci Res. 2020 Oct;159:9-15. doi: 10.1016/j.neures.2020.01.006. Epub 2020 Jan 23.
10
Mitochondrial Akt Signaling Modulated Reprogramming of Somatic Cells.
Sci Rep. 2019 Jul 9;9(1):9919. doi: 10.1038/s41598-019-46359-6.
Zotero 插件